市場調查報告書

醫用仿生藥物市場增長,趨勢,預測(2020-2025)

Medical Biomimetics Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946304
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格
醫用仿生藥物市場增長,趨勢,預測(2020-2025) Medical Biomimetics Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 117 Pages
簡介

預計在預測期內,醫用仿生物市場的複合年增長率為5.7%。市場增長的主要動力包括人口老齡化,器官衰竭增加和納米技術的進步。慢性腎臟疾病會損害腎臟並將其帶入功能障礙,據美國國家腎臟基金會稱,美國約有3700萬成年人患有慢性腎臟疾病,每年進行約3500次腎切除術。另外,在再生醫學中對仿生物的期望正在增加,其在各種疾病的治療中是有效的。

該報告調查了仿生物仿製藥市場,市場概況,市場增長因素和障礙因素分析,市場規模趨勢以及按產品類型/應用/區域,競爭情況,主要公司的預測我們提供有關公司資料,市場機會等的全面信息。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 納米技術的進步
    • 組織工程市場的增長
  • 市場障礙
    • 嚴格監管
  • 波特的五力分析

第5章市場細分

  • 按產品類型
    • 骨科
    • 眼科
    • 牙科
    • 其他
  • 按應用
    • 整形外科
    • 傷口處理
    • 人體組織工程
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第6章競爭情況

  • 公司簡介
    • Abbott
    • Avinent Science and Technology
    • Applied Biomimetic
    • Blatchford Ltd.
    • Biomimetic Solutions
    • CellCore
    • Forschungszentrum J-lich
    • SynTouch Inc.
    • Skyland Brand Ventures
    • Veryan Medical

第7章市場機會和未來趨勢

目錄
Product Code: 70637

The medical biomimetics market is expected to register a CAGR of 5.7% over the forecast period. The key contributor in the market growth are rising geriatric population, rising rates of organfailure and growing advancement in nanotechnology. Chronic kidney diseases damages the kidney and it couldn't function properly which leads to failure of kidneys. According to the National Kidney Foundation, around 37 million adult population in the United States suffer from chronic kidney diseases and around 3,500 kidneys are discarded every year. Furthermore, biomimetics holds a promising future in case of regenerative medicine for treating various diseases. Biomimetic nanoplatforms that can act as a drug delivery platform are capable of providing a better therapeutic efficinecy as a it contains both fabricated and biological components.

Key Market Trends

Orthopaedic is Expected to Exhibit a Significant Growth Over the Forecast Period

Orthopedic segment is expected to show a steady growth in the medical biomimetics market. Biomimetics bones have been developed to support the patients with the disability to walk. Many research studies are being conducted on for designing the calcium-phosphate protein templates. Biomineralisation process has been approached to imitate the real tissues with respect to the morphology, checmical and physical properties.

Furthermore, with the rising number of accidents the adoption of biomimetics in case of orthopedic is expected to boom. As per the data of Association for Safe International Road Travel, each year around 20 to 50 million people globally suffer from non-fatal injuries which leads to permanent diability. Hence, these factors are expected to influence positively on the market in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Medical Biomimetics market owing to increasing geriatric population, rising burden of chronic diseases and advancements in biomimetics. According to the U.S. Census Bureau, in 2018, around 52 million of people living in the United States are aged 65 and above. Older population is at higher risk of acquiring chronic diseases which sometimes leads to organ failure. According to the study of John Hopkins University, half of the people over 60 years are likely to develop kidney diseases. In addition to, according to the Centre for Disease Control and Prevention, almost 6 out of 10 adults in the America suffer from one or the other chronic disease. Hence, the aforementioned factors are expected to drive the medical biomimetic market in the North America.

Competitive Landscape

Key players in Medical Biomimetics market include Veryan Medical, SynTouch Inc., Blatchford Ltd., Skyland Brand Ventures, Avinent Science and Technology, Applied Biomimetic, Biomimetic Solutions, CellCore and Forschungszentrum Julich.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Advancement in Nanotechnology
    • 4.2.2 Growing Tissue Engineering Market
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Orthopedic
    • 5.1.2 Ophthalmology
    • 5.1.3 Dental
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Plastic Surgery
    • 5.2.2 Wound Healing
    • 5.2.3 Tissue Engineering
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Avinent Science and Technology
    • 6.1.3 Applied Biomimetic
    • 6.1.4 Blatchford Ltd.
    • 6.1.5 Biomimetic Solutions
    • 6.1.6 CellCore
    • 6.1.7 Forschungszentrum J-lich
    • 6.1.8 SynTouch Inc.
    • 6.1.9 Skyland Brand Ventures
    • 6.1.10 Veryan Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS